Enhanced human T cell expansion with inverse opal hydrogels

Area of Science:

• Biomaterials Engineering
• Immunology
• Cancer Therapy

Background:

• Personalized immunotherapies, including adoptive cell therapy (ACT), face challenges in producing sufficient therapeutic T cells efficiently.
• Current methods require improvement in cell yield, production time, and cost for routine clinical application.

Purpose of the Study:

• To engineer inverse opal (IOPAL) 3D hydrogels that mimic lymph node environments to enhance T cell proliferation.
• To evaluate the efficacy of IOPAL hydrogels in expanding primary human CD4+ T cells for ACT.

Main Methods:

• Development of poly(ethylene) glycol (PEG)-heparin based 3D hydrogels with controlled porosity using an IOPAL strategy.
• Culturing primary human CD4+ T cells within the engineered hydrogels and comparing proliferation against standard systems.

Main Results:

• IOPAL hydrogels significantly increased the proliferation of primary human CD4+ T cells compared to state-of-the-art expansion systems.
• The specific IOPAL architecture led to superior cell expansion versus hydrogels lacking this controlled pore structure.

Conclusions:

• IOPAL 3D hydrogels provide a beneficial architecture for significantly increasing therapeutic T cell numbers.
• This approach shows promise for overcoming limitations in cell expansion for adoptive cell therapy, maintaining desired T cell phenotypes.